Abiopharma

🔍 McMahon Robert W. (Executive)

Company: WEST PHARMACEUTICAL SERVICES INC (WST)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 794 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,774.96 | transaction_form_type: 4 | Footnotes: F1
• Sold 346 shares of Common Stock at $351.37 per share (Direct)
  Date: 2026-08-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 3,429.45 | transaction_form_type: 4
• Acquired 6,355 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,784.18 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,764 shares of Common Stock at $351.37 per share (Direct)
  Date: 2026-08-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,020.51 | transaction_form_type: 4
• Sold 6,355 shares of Rst. Stock Unit (Derivative)
  Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,118.58 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 794 shares of Rst. Stock Unit (Derivative)
  Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,383.40 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of WST common stock.
• F2: On August 11, 2025, the reporting person was granted 12,670 restricted stock units, vesting in three installments - 4,223 shares (plus dividend equivalents) to vest six months from the grant date, 6,335 shares (plus dividend equivalents) to vest 12 months from the grant date and 2,112 shares (plus dividend equivalents) to vest 24 months from the grant date.
• F3: This award vests in four equal annual installments beginning on August 11, 2026.